Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination

Novel mRNA vaccines for SARS-CoV2 have been authorized for emergency use and are currently being administered to millions of individuals worldwide. Despite their efficacy in clinical trials, there is limited data on vaccine-induced immune responses in individuals with a prior SARS-CoV2 infection com...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Rishi R., Apostolidis, Sokratis A., Painter, Mark M., Mathew, Divij, Pattekar, Ajinkya, Kuthuru, Oliva, Gouma, Sigrid, Kuri-Cervantes, Leticia, Meng, Wenzhao, Adamski, Sharon, Baxter, Amy E., Giles, Josephine R., Weirick, Madison E., McAllister, Christopher M., Hicks, Amanda, Korte, Scott, Dougherty, Jeanette, Long, Sherea, D’Andrea, Kurt, Hamilton, Jacob T., Prak, Eline T Luning, Betts, Michael R., Bates, Paul, Hensley, Scott E., Greenplate, Allison R., Wherry, E. John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941668/
https://www.ncbi.nlm.nih.gov/pubmed/33688691
http://dx.doi.org/10.1101/2021.03.03.21252872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941668/
https://www.ncbi.nlm.nih.gov/pubmed/33688691
http://dx.doi.org/10.1101/2021.03.03.21252872

Ejemplares similares